 |
| |
|
SPS3, Secondary
Prevention of
Small Subcortical Strokes Trial
|
| |
Sponsor |
| |
|
National Institute of Neurological
Disorders and Stroke (NINDS), National Institutes of Health (NIH) |
| |
Principal Investigator |
| |
|
Oscar Benavente, MD, University of Texas Health
Science Center, San Antonio, Texas |
| |
Berman Center Site Investigators |
| |
|
Principal Investigator:
David Anderson, MD, Chair, Neurology Service, HCMC & Department
of Neurology, University of Minnesota
Co-Investigators:
Scott Bundlie, MD, Neurology, HCMC
Richard Grimm, MD, MPH, PhD, Berman Center for Outcomes & Clinical
Research |
| |
Berman Center Site Coordinator |
| |
|
Donna
Brauer, PhD, RN
612-347-4420 |
| |
Description |
| |
|
The goal of this study is to identify the optimal
combinations of antiplatelet therapy (aspirin and clopidogrel vs.
aspirin alone) and blood pressure control (intensive vs. less intensive
control) for preventing recurrent strokes and cognitive decline
in patients who have experienced a small sub-cortical stroke.
 |
| |
|
|
| |
|
|
|
|
|
 |
 |
